MERIT MEDICAL SYSTEMS INC
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
MMSI$88.42+1.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| | | | |
|---|---|---|---|
| PART I | | | |
| | | | |
| Item 1. | Business | | 3 |
| | | | |
| Item 1A. | Risk Factors | | 20 |
| | | | |
| Item 1B. | Unresolved Staff Comments | | 35 |
| | | | |
| Item 1C. | Cybersecurity | | 35 |
| | | | |
| Item 2. | Properties | | 36 |
| | | | |
| Item 3. | Legal Proceedings | | 36 |
| | | | |
| Item 4. | Mine Safety Disclosures | | 36 |
| | | | |
| PART II | | | |
| | | | |
| Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | | 37 |
| | | | |
| Item 6. | Reserved | | 38 |
| | | | |
| Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | | 39 |
| | | | |
| Item 7A. | Quantitative and Qualitative Disclosures About Market Risk | | 46 |
| | | | |
| Item 8. | Financial Statements and Supplementary Data | | 47 |
| | | | |
| Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | | 92 |
| | | | |
| Item 9A. | Controls and Procedures | | 92 |
| | | | |
| Item 9B. | Other Information | | 94 |
| | | | |
| PART III | | | |
| | | | |
| Item 10. | Directors, Executive Officers and Corporate Governance | | 94 |
| | | | |
| Item 11. | Executive Compensation | | 94 |
| | | | |
| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | | 94 |
| | | | |
| Item 13. | Certain Relationships and Related Transactions and Director Independence | | 94 |
| | | | |
| Item 14. | Principal Accountant Fees and Services | | 94 |
| | | | |
| PART IV | | | |
| | | | |
| Item 15. | Exhibits and Financial Statement Schedules | | 94 |
| | | | |
| | | | |
| SIGNATURES | | 103 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.